A once-scrapped Alzheimer’s drug may work after all, new analyses suggest

At the highest doses, aducanumab slowed mental decline, the drug developer claims

amyloid

By targeting sticky globs of amyloid (red) in the brains of people with Alzheimer’s, a new drug may offer a way to slow the disease’s spread.

Martin M. Rotker/Science Source

Call it a comeback — maybe. After being shelved earlier this year for lackluster preliminary results, a drug designed to slow Alzheimer’s progression is showing new signs of life.